MDAL
From Wikipedia, the free encyclopedia
| MDAL | |
|---|---|
 |
|
| IUPAC name | N-[1-(1,3-benzodioxol-5-yl)propan-2-yl]prop-2-en-1-amine |
| Identifiers | |
| CAS number | |
| SMILES | C1=C2C(=CC=C1CC(C)NCC=C)OCO2 |
| Properties | |
| Molecular formula | C13H17NO2 |
| Molar mass | 219.283 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references |
|
MDAL, or 3,4-methylenedioxy-N-allylamphetamine, is a lesser-known psychedelic drug. It is also the N-allyl isomer of MDA. MDAL was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 180mg, and the duration unknown. MDAL produces few to no effects on its own, but may enhance the effects of LSD. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDAL.
[edit] See also
[edit] External links
|
|||||
 |
This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |
